Skip to content

Elena Koning

9 papers in the library · 28 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions

International Journal of Eating Disorders July 2, 2026 Elena Koning, Jérémie Richard, Aaron Keshen

OBJECTIVE: Eating disorders (EDs) are characterized by high rates of psychiatric comorbidity and suboptimal treatment outcomes. There remain critical gaps in research, including the exploration of effective transdiagnostic interventions. This forum article examines the potential of psilocybin treatment (PT) as a transdiagnostic intervention for EDs and common comorbidities, including the...

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development.

Behavioral sciences (Basel, Switzerland) March 6, 2026 Elena Koning, Susan Gamberg, Aaron Keshen 1 citation

Eating disorders (EDs) remain challenging to treat, with high dropout and low remission rates in cognitive-behavioral therapy for EDs (CBT-ED). Psilocybin treatment (PT) demonstrates therapeutic potential to enhance CBT-ED by exerting several neurobiological, psychological, and experiential effects (e.g., antidepressant, neuroplasticity, emotional openness) that are hypothesized to increase...

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development

Preprints.org December 19, 2025 Elena Koning, Susan Gamberg, Aaron Keshen preprint

Eating disorders (ED) remain challenging to treat, with high dropout and low remission rates in cognitive-behavioral therapy for EDs (CBT-ED). Psilocybin treatment (PT) demonstrates therapeutic potential to enhance CBT-ED by exerting several neurobiological, psychological, and experiential effects (e.g., antidepressant, neuroplasticity, emotional openness) that are hypothesized to increase...

Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.

J Eat Disord September 2, 2025 Elena Koning, Riccardo Miceli Mcmillan, Aaron Keshen et al. 3 citations

Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.

The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication.

Trends in Psychiatry and Psychotherapy 2025 Elena Koning, Marco Solmi, Elisa Brietzke 4 citations

Psychedelics are a group of psychoactive substances that produce complex and subjective changes to consciousness and carry unique safety considerations. There is a growing body of work investigating the use of psychedelics in mental health treatment alongside increasing socio-cultural and political acceptance. This rapid evolution has prompted corporations to fund psychedelic clinical trials,...

Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?

Trends in Psychiatry and Psychotherapy 2025 Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves et al.

Although each PAP model differs, both may have clinical relevance in depression treatment. Future work should explore the standardized reporting of psychological interventions in PAP and comparative study designs to better evaluate non-specific and specific models and inform treatment guidelines.

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design

Journal of Eating Disorders December 27, 2024 Elena Koning, Cristiano Chaves, Elisa Brietzke et al. 2 citations

Eating disorders (EDs) are a group of debilitating mental illnesses characterized by maladaptive eating behaviors and severe cognitive-emotional dysfunction, directly affecting 1-3% of the population. Standard treatments are not effective in approximately one third of ED cases, representing the need for scientific advancement. There is emerging evidence for the safety and efficacy of...

The historical opposition to psychedelic research and implications for credibility in psychiatry.

CNS Spectrums November 21, 2024 Elena Koning, Elvina M Chu, Elisa Brietzke 5 citations

Psychedelics are a group of psychoactive substances that alter consciousness and produce marked shifts in sensory perception, cognition, and mood. Although psychedelics have been used by indigenous communities for centuries, they have only recently been investigated as an adjunctive therapeutic tool in psychotherapy. Since the early twentieth century, psychedelic-assisted psychotherapy has been...

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence

Trends in Psychiatry and Psychotherapy May 1, 2023 Elena Koning, Elisa Brietzke 13 citations

Eating disorders (ED) are a group of potentially severe mental disorders characterized by abnormal energy balance, cognitive dysfunction, and emotional distress. Cognitive inflexibility is a major challenge to successful ED treatment and dysregulated serotonergic function has been implicated in this symptomatic dimension. Moreover, there are few effective treatment options and long-term...